Incordex Corp. financial data

Symbol
ICDX on OTC
Location
6 Rosemary Way, Nuneaton, United Kingdom
State of incorporation
NV
Fiscal year end
June 30
Latest financial report
10-Q - Q3 2024 - Nov 6, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 40.7 %
Debt-to-equity -4.06K % -1100%
Return On Equity 995 %
Return On Assets -25.1 % +35.8%
Operating Margin -23.7 % +56.2%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 6.45M shares 0%
Common Stock, Shares, Outstanding 6.45M shares 0%
Entity Public Float 0 USD
Common Stock, Value, Issued 6.45K USD 0%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 28.2K USD +97.6%
General and Administrative Expense 47.4K USD +116%
Operating Income (Loss) -6.68K USD +13.4%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -6.68K USD +13.4%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 5.39K USD -43.6%
Assets, Current 2.23K USD -94.7%
Assets 21.8K USD -49.8%
Accounts Payable, Current 2.38K USD -92.1%
Liabilities, Current 2.38K USD -92.1%
Liabilities 26.4K USD -36.1%
Retained Earnings (Accumulated Deficit) -38.6K USD -20.9%
Stockholders' Equity Attributable to Parent -4.62K USD -324%
Liabilities and Equity 21.8K USD -49.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -3.76K USD -30.3%
Net Cash Provided by (Used in) Financing Activities 5K USD +25%
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares Authorized 75M shares 0%
Common Stock, Shares, Issued 6.45M shares 0%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 2.23K USD -65.7%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD
Depreciation 416 USD 0%
Additional Paid in Capital 27.6K USD 0%
Depreciation, Depletion and Amortization 1.75K USD +320%